Supha Pharmachem share news and announcements

BSE: 539561Commercial Services & SuppliesSmall Cap

₹0.24₹0.01 (4.00%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹0.25.

52-week range of traded prices to 23 Oct 2026

₹0.23Low, 22 Oct 2026₹1.66High, 4 Nov 2025

Market cap: ₹21 Cr3,473rd largest listed
P/E: No recent results
P/B: No recent results
Dividend yield: Nonein the last 12 months
Volume, BSE: 72,65,991

Supha Pharmachem share news and announcements

496 announcements, routine notices left out, newest first. Page 4 of 10.

Feb 2024
- 23 Feb · Board meeting
  Meeting on 7 Mar 2024
- 23 Feb · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 07/03/2024 ,inter alia, to consider and approve Intimation of Board Meeting .... (opens in a new tab)
- 19 Feb · Corporate action
  With reference to the captioned subject, we would like to inform you that Company has received NEW ISIN from CDSL and NSDL pursuant to sub division/ stock split of Face Value of the Equity .... (opens in a new tab)
- 14 Feb · Results
  Unaudited Financial Results for The Quarter and Nine Months Ending 31.12.2023 (opens in a new tab)
- 14 Feb · Board meeting
  Approval of Financial Result on Board Meeting held on Wednesday, February 14, 2024 (opens in a new tab)
- 12 Feb · Meeting
  Company has approved Record date for Stock Split (Sub-division) of equity share of Rs.5/- per equity share to Re.1/- per equity share through Postal Ballot. (opens in a new tab)
- 12 Feb · Meeting
  Postal Ballot- Scrutinizer's Report for Postal Ballot Notice dated January 08, 2024. (opens in a new tab)
- 12 Feb · Meeting
  Postal Ballot Result for copy of Postal Ballot Notice seeking approval of the members for the resolutions dated January 08, 2024. (opens in a new tab)
- 6 Feb · Board meeting
  Meeting on 14 Feb 2024: quarterly results
- 6 Feb · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 14/02/2024 ,inter alia, to consider and approve the Unaudited Financial Results .... (opens in a new tab)
- 5 Feb · Management
  With reference to Corporate Announcement under regulation 30 of SEBI(LODR), 2015 in relation to reporting Resignation of Company Secretary & Compliance Officer of the Company to the Stock .... (opens in a new tab)
- 5 Feb · Management
  With reference to our Announcement under Regulation 30 of SEBI(LODR), 2015 in relation to change in directorship submitted to the Exchange as on September 05, 2023. We wish to resubmit .... (opens in a new tab)
Jan 2024
- 10 Jan · Meeting
  Postal Ballot Notice dated January 08, 2024. (opens in a new tab)
- 8 Jan · Board meeting
  1. Sub-division (stock split) of every 1(one) equity share of face value Rs. 5/- each into 5 (five) equity share of face value of Re.1/- 2.Alteration of Capital clause of the Memorandum .... (opens in a new tab)
- 2 Jan · Board meeting
  Meeting on 8 Jan 2024: stock split
- 2 Jan · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 08/01/2024 ,inter alia, to consider and approve sub-division of shares/ stock .... (opens in a new tab)
Dec 2023
- 18 Dec · Legal
  Clarification on Price Movement (opens in a new tab)
- 8 Dec · Legal
  Exchange has sought clarification from Remedium Lifecare Ltd on December 8, 2023 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Nov 2023
- 21 Nov · Management
  Company has appointed Mrs. Dhwani Desai (ICSI Membership No. A63688) as a Company Secretary & Compliance Officer of the Company w.e.f. 20.11.2023. (opens in a new tab)
- 11 Nov · Results
  Unaudited Financial Results for the quarter and half year ending 30.09.2023 (opens in a new tab)
- 11 Nov · Board meeting
  Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended 30.09.2023 (opens in a new tab)
- 6 Nov · Board meeting
  Meeting on 11 Nov 2023: quarterly results
- 4 Nov · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 11/11/2023 ,inter alia, to consider and approve the Unaudited Financial Results .... (opens in a new tab)
Sep 2023
- 8 Sep · Management
  Resignation of Ms.Ashvini Dhuri(Membership No.A66051), as a Company Secretary & Compliance Officer of the Company. (opens in a new tab)
- 5 Sep · Management
  Intimation under Regulation 30 of SEBI (LODR) Regulations 2015- Resignation of Whole Time Director. (opens in a new tab)
- 5 Sep · Management
  Intimation under Regulation 30 of SEBI (LODR)Regulations 2015- Change in Directorate. (opens in a new tab)
- 5 Sep · Board meeting
  Outcome of the Board Meeting held on 05.09.2023 (opens in a new tab)
Aug 2023
- 29 Aug · Corporate action
  Please find enclosed herewith Copy of Letter sent to the shareholders holding shares in physical form, requesting them to provide their demat account details to the Company or Skyline Financial .... (opens in a new tab)
- 28 Aug · Intimation To Shareholders Holding Shares In Physical Mode Regarding Mandatory Furnishing Of PAN, KYC Nomination And Bank Details As Per SEBI Circular Dated March 16, 2023.
  Read with SEBI Circular No. SEBI/HO/MIRSD/MIRSD-PoD-1/P/CIR/2023/37 dated .... (opens in a new tab)
- 28 Aug · Board meeting
  Meeting on 5 Sep 2023
- 26 Aug · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 05/09/2023 ,inter alia, to consider and approve Remedium Lifecare Limited .... (opens in a new tab)
- 23 Aug · Intimation Of New ISIN For Remedium Lifecare Limited.
  With reference to the captioned subject,we would like to inform you that Remedium Lifecare Limited has received NEW ISINfrom CDSL and NSDL pursuant to Subdivision/Stock Split of Face Value .... (opens in a new tab)
- 12 Aug · Results
  Results for the Quarter ended June 30, 2023. (opens in a new tab)
- 12 Aug · Results
  Outcome of Board Meeting held on Saturday, August 12, 2023. (opens in a new tab)
- 8 Aug · Sub- Division Of Face Value Of Rs. 10/-Each To Face Value Of Rs. 5/-Each.
  Company has fixed Friday, September 01, 2023 as the Record Date for the purpose of ascertaining the names of the Shareholders who would be entitled to receive 2(Two) Equity Shares of .... (opens in a new tab)
- 3 Aug · Board meeting
  Meeting on 12 Aug 2023: quarterly results
- 3 Aug · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 12/08/2023 ,inter alia, to consider and approve the Un-Audited Financial .... (opens in a new tab)
- 1 Aug · Business
  Intimation pursuant to regulation 30 of the SEBI (LODR) Regulation 2015 Regarding receipt of "Best Returns to the Investors Award" at Brandscouncil Ratings & Medilinks India Awards 2023 .... (opens in a new tab)
Jul 2023
- 31 Jul · Announcement under Regulation 30 (LODR)-Allotment
  We wish to inform you that our Company, Remedium Lifecare Limited ("the Company") in its Board Meeting held on July 31, 2023 have allotted 64,80,000 Equity Shares of Rs.10/-each as fully .... (opens in a new tab)
- 21 Jul · Meeting
  Regulations 30 and 44 read with Schedule III of SEBI LODR Regulations 2015 showing revised format of Voting Result alongwith Scrutinizer's Report. (opens in a new tab)
- 20 Jul · Meeting
  Scrutinizer Report and E- Voting Result for 34th Annual General Meeting held on 20.07.2023. (opens in a new tab)
- 20 Jul · Meeting
  Outcome of 34th AGM held on 20.07.2023. (opens in a new tab)
- 4 Jul · Compliance-57 (5) : intimation after the end of quarter
  Non-Applicability of Reg 57(5) of SEBI (LODR) Regulations, 2015 for the quarter ended June 2023. (opens in a new tab)
Jun 2023
- 26 Jun · Meeting
  34th Annual General Meeting (AGM) of the Company will be held on Thursday, 20th July, 2023 at 11.00 am through VC/OAVM. Book Closure: From Friday 14th July, 2023 to Thursday 20th July, .... (opens in a new tab)
- 26 Jun · Meeting
  34th Annual General Meeting (AGM) of the Company will be held on Thursday, 20th July, 2023 at 11.00 a.m. (IST) through Video Conferencing (VC) / Other Audio Visual Means (OAVM (opens in a new tab)
- 23 Jun · Corporate action
  In terms of Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, as amended, we inform you that Remedium Lifecare Limited ('the Company') has fixed .... (opens in a new tab)
- 23 Jun · Board meeting
  Board of Directors of the Company at their meeting held on 23/06/2023 ,inter alia, had considered and approved the: 1. Issue of Bonus .... (opens in a new tab)
- 14 Jun · Board meeting
  Meeting on 23 Jun 2023: bonus issue and stock split
- 14 Jun · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 23/06/2023 ,inter alia, to consider and approve 1. issue of Bonus Shares .... (opens in a new tab)
May 2023
- 31 May · Announcement under Regulation 30 (LODR)-Change in Registered Office Address
  Board of Directors of the company at their meeting held on 30.05.2023, has approved the shifting of the registered office of the company from existing address at Office No. 601, Hyde .... (opens in a new tab)

Supha Pharmachem share news and announcements

Feb 2024

Jan 2024

Dec 2023

Nov 2023

Sep 2023

Aug 2023

Jul 2023

Jun 2023

May 2023